135 related articles for article (PubMed ID: 11711262)
1. Effects of food intake and age on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic. Comparison with cefpodoxime proxetil.
Totsuka K; Shimizu K; Mori N; Sugihara T; Sakai A; Yamaji S; Michisuji Y; Shinohara Y; Kubo A; Tokuoka H
Int J Antimicrob Agents; 2001 Nov; 18(5):463-9. PubMed ID: 11711262
[TBL] [Abstract][Full Text] [Related]
2. Effects of the quantity of water and milk ingested concomitantly with AS-924, a novel ester-type cephem antibiotic, on its pharmacokinetics.
Matsumoto F; Sakurai I; Morita M; Takahashi T; Mori N; Sugihara T; Sakai A; Yamaji S; Akaike Y; Yano K
Int J Antimicrob Agents; 2001 Nov; 18(5):471-6. PubMed ID: 11711263
[TBL] [Abstract][Full Text] [Related]
3. Effect of antacid pretreatment on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic--comparison with cefteram-pivoxil.
Totsuka K; Shimizu K; Mori N; Sugihara T; Sakai A; Yamaji S; Michisuji Y; Shinohara Y; Kubo A; Tokuoka H
Int J Antimicrob Agents; 2001 Nov; 18(5):477-82. PubMed ID: 11711264
[TBL] [Abstract][Full Text] [Related]
4. Effects of gastrointestinal stimulant and suppressant pretreatment on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic.
Yanagawa A; Shimada J; Mori N; Sugihara T; Sakai A; Yamaji S; Yano K; Kitamura T; Kano T
Int J Antimicrob Agents; 2001 Nov; 18(5):483-7. PubMed ID: 11711265
[TBL] [Abstract][Full Text] [Related]
5. Effect of timing of food on absorption of cefpodoxime proxetil.
Borin MT; Driver MR; Forbes KK
J Clin Pharmacol; 1995 May; 35(5):505-9. PubMed ID: 7657851
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses.
Tremblay D; Dupront A; Ho C; Coussediere D; Lenfant B
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():21-8. PubMed ID: 2292526
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.
Saathoff N; Lode H; Neider K; Depperman KM; Borner K; Koeppe P
Antimicrob Agents Chemother; 1992 Apr; 36(4):796-800. PubMed ID: 1354432
[TBL] [Abstract][Full Text] [Related]
8. Effect of food on absorption of cefpodoxime proxetil oral suspension in adults.
Borin MT; Forbes KK
Antimicrob Agents Chemother; 1995 Jan; 39(1):273-5. PubMed ID: 7695323
[TBL] [Abstract][Full Text] [Related]
9. AS-924, a novel, orally active, bifunctional prodrug of ceftizoxime: physicochemical properties, oral absorption in animals, and antibacterial activity.
Mori N; Kodama T; Sakai A; Suzuki T; Sugihara T; Yamaguchi S; Nishijima T; Aoki A; Toriya M; Kasai M; Hatano S; Kitagawa M; Yoshimi A; Nishimura K
Int J Antimicrob Agents; 2001 Nov; 18(5):451-61. PubMed ID: 11711261
[TBL] [Abstract][Full Text] [Related]
10. The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil.
Hughes GS; Heald DL; Barker KB; Patel RK; Spillers CR; Watts KC; Batts DH; Euler AR
Clin Pharmacol Ther; 1989 Dec; 46(6):674-85. PubMed ID: 2557183
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil.
Borin MT; Hughes GS; Patel RK; Royer ME; Cathcart KS
J Clin Pharmacol; 1991 Dec; 31(12):1137-45. PubMed ID: 1761737
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil.
Gehanno P; Andrews JM; Ichou F; Sultan E; Lenfant B
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():47-51. PubMed ID: 2292530
[TBL] [Abstract][Full Text] [Related]
13. A review of the pharmacokinetics of cefpodoxime proxetil.
Borin MT
Drugs; 1991; 42 Suppl 3():13-21. PubMed ID: 1726203
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, protein binding, and tissue distribution of orally administered cefpodoxime proxetil and cephalexin in dogs.
Papich MG; Davis JL; Floerchinger AM
Am J Vet Res; 2010 Dec; 71(12):1484-91. PubMed ID: 21118001
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical and pharmacokinetic characterization of a spray-dried cefpodoxime proxetil nanosuspension.
Gao Y; Qian S; Zhang J
Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):912-7. PubMed ID: 20606336
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine.
Kees F; Wellenhofer M; Bröhl K; Grobecker H
Arzneimittelforschung; 1996 Apr; 46(4):435-8. PubMed ID: 8740095
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of cefpodoxime proxetil in healthy young and elderly volunteers.
Borin MT; Ferry JJ; Forbes KK; Hughes GS
J Clin Pharmacol; 1994 Jul; 34(7):774-81. PubMed ID: 7929873
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and ex vivo susceptibility of cefpodoxime proxetil in patients receiving continuous ambulatory peritoneal dialysis.
Johnson CA; Ateshkadi A; Zimmerman SW; Hughes GS; Craig WA; Carey PM; Borin MT
Antimicrob Agents Chemother; 1993 Dec; 37(12):2650-5. PubMed ID: 8109931
[TBL] [Abstract][Full Text] [Related]
19. Human skin disposition of cefpodoxime after oral administration of its proxetil ester.
Zolfino I; Senesi S; Campa M; Di Vito A; Mosca F; Favini P; Ducci M; Danesi R; Del Tacca M
J Antimicrob Chemother; 1992 Nov; 30(5):731-3. PubMed ID: 1493994
[No Abstract] [Full Text] [Related]
20. The bioavailability of cefpodoxime proxetil tablets relative to an oral solution.
Borin MT; Forbes KK; Hughes GS
Biopharm Drug Dispos; 1995 May; 16(4):295-302. PubMed ID: 7548778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
